Insiders at Altimmune, Inc. collectively show a net loss of US$29,000 on their holdings, even after recent positive movements in the company's share price. This indicates that while the stock has seen some recovery, it has not yet reached levels where insiders are profitable.
Altimmune Insiders Remain Underwater Despite Recent Share Gains
insider-tradingbiotechstock-performanceinvestor-sentiment
